Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Marker Therapeutics Inc banner

Marker Therapeutics Inc
NASDAQ:MRKR

Watchlist Manager
Marker Therapeutics Inc Logo
Marker Therapeutics Inc
NASDAQ:MRKR
Watchlist
Price: 1.48 USD -10.3% Market Closed
Market Cap: $24.7m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MRKR Price Targets Summary
Marker Therapeutics Inc

Wall Street analysts forecast MRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRKR is 9.21 USD with a low forecast of 5.66 USD and a high forecast of 13.13 USD.

MRKR Lowest Forecast
Wall Street Target
5.66 USD
282% Upside
MRKR Average Forecast
Wall Street Target
9.21 USD
522% Upside
MRKR Highest Forecast
Wall Street Target
13.13 USD
787% Upside
Lowest
Price Target
5.66 USD
282% Upside
Average
Price Target
9.21 USD
522% Upside
Highest
Price Target
13.13 USD
787% Upside
Marker Therapeutics Inc Competitors:
Price Targets
HCAT
Health Catalyst Inc
91% Upside
NCSM
NCS Multistage Holdings Inc
26% Upside
TCPC
BlackRock TCP Capital Corp
35% Upside
ACIU
AC Immune SA
199% Upside
HCAT
Health Catalyst Inc
91% Upside
NCSM
NCS Multistage Holdings Inc
26% Upside
TCPC
BlackRock TCP Capital Corp
35% Upside
ACIU
AC Immune SA
199% Upside

Revenue
Forecast

N/A
Past Growth
109% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
109% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss

What are analyst estimates?

See Also

Summary
MRKR intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRKR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRKR stock valuation using valuation multiples.
Wall Street Estimates
MRKR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRKR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRKR's stock price target?
Price Target
9.21 USD

According to Wall Street analysts, the average 1-year price target for MRKR is 9.21 USD with a low forecast of 5.66 USD and a high forecast of 13.13 USD.

What is Marker Therapeutics Inc's Revenue forecast?
Projected CAGR
109%

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.